|
4 Companies |
|
2 Products |
|
2 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
10 News |
|
- | sirolimus / Generic mfg.
Trial withdrawal: Sirolimus for the Treatment of Hyperinsulinism (clinicaltrials.gov) - Jun 13, 2018
P1/2, N=0, Withdrawn, Sponsor: Children's Hospital of Philadelphia
Recruiting --> Withdrawn
- | sirolimus / Generic mfg.
Trial primary completion date: Sirolimus for the Treatment of Hyperinsulinism (clinicaltrials.gov) - Sep 21, 2017
P1/2, N=6, Recruiting, Sponsor: Children's Hospital of Philadelphia
Recruiting --> Withdrawn Trial primary completion date: Jun 2017 --> Jun 2018
- RZ358 / Rezolute
Trial completion, Trial primary completion date: A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism (clinicaltrials.gov) - Feb 6, 2017
P2, N=10, Completed, Sponsor: XOMA (US) LLC
Trial primary completion date: Jun 2017 --> Jun 2018 Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Jan 2017
- | RZ358 / Rezolute
New P2 trial: A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism (clinicaltrials.gov) - Nov 14, 2015
P2, N=12, Recruiting, Sponsor: XOMA (US) LLC
- sirolimus / Generic mfg.
Enrollment open: Sirolimus for the Treatment of Hyperinsulinism (clinicaltrials.gov) - Sep 16, 2015
P1/2, N=6, Recruiting, Sponsor: Children's Hospital of Philadelphia
Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Jan 2017 Not yet recruiting --> Recruiting
- sirolimus / Generic mfg.
New P1/2 trial: Sirolimus for the Treatment of Hyperinsulinism (clinicaltrials.gov) - Aug 17, 2015
P1/2, N=6, Not yet recruiting, Sponsor: Children's Hospital of Philadelphia
- avexitide (exendin 9-39) / Eiger
Trial completion: Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism (clinicaltrials.gov) - Mar 14, 2015
P1/2, N=10, Completed, Sponsor: Diva De Leon
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial completion, Surgery: non-focal CHI: Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism (clinicaltrials.gov) - Apr 7, 2014
P=N/A, N=14, Completed, Sponsor: University Medicine Greifswald
Active, not recruiting --> Completed Not yet recruiting --> Completed
- octreotide acetate solution for injection / Generic mfg.
Trial completion: Sandostatine® LP and Hyperinsulinism (clinicaltrials.gov) - Dec 17, 2013
P2, N=10, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting --> Completed Active, not recruiting --> Completed